Approval · Notice of Compliance 27216 · 2021
ETODOLAC: Notice of Compliance 27216
Issued December 10, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27216
- Date
- December 10, 2021
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- ULTRADOL (Procter & Gamble Pharmaceuticals Canada, Inc)